2. Biomarkers in Heart Failure
- Barry H. Greenberg2,
- Denise D. Barnard2,
- Sanjiv M. Narayan3,
- John R. Teerlink4,5
Published Online: 14 SEP 2010
DOI: 10.1002/9780470669402.ch2
Copyright © 2010 John Wiley & Sons Ltd
Book Title

Management of Heart Failure
Additional Information
How to Cite
Slavin, L., Ro, T. K. and Maisel, A. S. (2010) Biomarkers in Heart Failure, in Management of Heart Failure (eds B. H. Greenberg, D. D. Barnard, S. M. Narayan and J. R. Teerlink), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470669402.ch2
Editor Information
- 2
Division of Cardiology, University of California, San Diego, California, USA
- 3
University of California and Veterans Affairs Medical Center, San Diego, California, USA
- 4
Section of Cardiology, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA
- 5
School of Medicine, University of California, San Francisco, California, USA
Publication History
- Published Online: 14 SEP 2010
- Published Print: 8 OCT 2010
ISBN Information
Print ISBN: 9780470753798
Online ISBN: 9780470669402
- Summary
- Chapter
- References
Keywords:
- biomarkers in heart failure;
- heart failure (HF), serious public health matters in modern medicine;
- Natriuretic peptides (NP), released by cardiac myocytes - in response to wall stress from intravascular volume expansion;
- desired properties - of ideal biomarker;
- natriuretic peptide subtypes and their actions;
- synthesis and processing of B-type natriuretic peptide;
- non-NP biomarkers of interest in heart failure;
- MR-proADM, new biomarker - reflecting myocardial stretch, increasing in patients with HF;
- neutrophil gelatinase-associated lipocalin (NGAL);
- biomarker role, emerging as important tool - in basic and clinical heart failure
Summary
This chapter contains sections titled:
Introduction
Biomarkers
Natriuretic peptides
Non-natriuretic peptides of interest in heart failure
ST-2
Adrenomedullin
Troponin
C-reactive protein
Neutrophil gelatinase-associated lipocalin (NGAL)
The future
References
